Before joining Boston University to study biomedical engineering and chemistry, Mass Innovation Labs founder Amrit Chaudhuri was the youngest paid researcher at the MIT-affiliated Whitehead Institute for Biomedical Research, at age 15.
Explaining the origin of the firm, he says that "the idea of spending 20 years to go down the academic path hit me very hard. I thought I'd end up working on projects I didn't want to work on, and I have so many of my own.”
"The idea of starting a company was very interesting, but the ton of bricks that then hits you is - how do you fund it? How is that financially feasible? I spent a couple of years looking at how investment in biotech works."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze